// App-Quantinova.ai

T4035 2016 AHA : Elabela, a Novel Apj-receptor Agonist, Improves Fluid Homeostasis and Reduces Cardio-renal Dysfunction During Acute Heart Failure (AHF)

Researchers

Presenter

  • Xavier Sainsily

Principal Investigators

  • Frederic Chagnon

  • Alexandre Murza

  • Lauralyne Dumont

  • Robert Dumaine

  • philippe Sarret

  • Eric Marsault

  • Dan Salvail

  • Mannix Auger-Messier

  • Olivier lesur

Medical Centers

  • Universite de Sherbrooke, Sherbrooke, QC, Canada

  • IPS Therapeutique Inc., Sherbrooke, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Urology

Disease

  • Myocardial Dysfunction

  • Systemic inflammation

  • Congestive heart failure

  • Renal insufficiency

  • Microalbuminuria

  • Acute renal failure

  • Albuminuria

Biomarkers

  • Creatinine

  • Hepatitis A virus cellular receptor 1

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved